API
< Back to all clusters
[BUSINESS] · United States · 2 sources

started · updated

Biotech stocks CareDx and Grail Inc. hit 52-week highs

Several biotechnology stocks reached 52-week highs on September 24, 2026, following significant regulatory and clinical developments.

CareDx Inc. (CDNA) saw its stock rise over 13% to a high of $63.09. The company recently secured Medicare coverage for its AlloSure, AlloMap, and AlloSeq systems, which assist in detecting allograft rejection in kidney, heart, and lung transplant patients. CareDx also reported a 52% year-over-year increase in second-quarter revenue, reaching $132 million.

Grail Inc. (GRAL) shares increased by over 15% to a 52-week high of $126.81. This surge follows a positive recommendation from the FDA's Medical Devices Advisory Committee regarding the company's Galieri multi-cancer early detection (MCED) test. An FDA decision on premarket approval is expected in the coming months.

Entities

CareDx Inc. · Grail Inc. · Medicare · U.S. Food and Drug Administration